RGC · Regencell Bioscience Holdings Ltd
United States · RS rating 26 · As of 2026-11-03
| Price | 6.15 USD |
|---|---|
| 1-day change | -2.2% |
| RS rating (overall / 1M / 3M / 12M) | 26 / 27 / 76 / 15 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 16 / 4 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +88.4% |
| Market cap (USD) | $14.0B |